These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 12120625)

  • 1. [Guidelines for cardiovascular prevention in diabetic patients].
    ; ; ; ; ; ; ; ;
    Ital Heart J Suppl; 2002 Jun; 3(6):669-76. PubMed ID: 12120625
    [No Abstract]   [Full Text] [Related]  

  • 2. [Primary prevention of cardiovascular disease].
    Gohlke H
    Dtsch Med Wochenschr; 2005 Jan; 130(1-2):38-43. PubMed ID: 15619173
    [No Abstract]   [Full Text] [Related]  

  • 3. [Aspirin therapy for cardiovascular prevention in the diabetic patient: what have we learned from the evidence?].
    Legrand DA; Scheen AJ
    Rev Med Suisse; 2006 Aug; 2(76):1904-8. PubMed ID: 16972540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Policy paper on primary prevention of cardiovascular diseases. Current draft of 3/25/2003 issued by the Executive Committee of the German Society of Cardiology, Heart and Circulation Research. Edited by the Prevention Project Group on behalf of the Executive Committee].
    Gohlke H; Kübler W; Mathes P; Meinertz T; Schuler G; Gysan DB; Sauer G;
    Z Kardiol; 2003 Jun; 92(6):522-3. PubMed ID: 12905981
    [No Abstract]   [Full Text] [Related]  

  • 5. Primary prevention of cardiovascular events and type 2 diabetes: should we prioritize our interventions?
    Sultan A; Thuan JF; Avignon A
    Diabetes Metab; 2006 Dec; 32(6):559-67. PubMed ID: 17296509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of cardiovascular events in diabetes.
    Malcolm J; Meggison H; Sigal R
    Clin Evid; 2003 Dec; (10):690-714. PubMed ID: 15555116
    [No Abstract]   [Full Text] [Related]  

  • 7. Prevention of cardiovascular events in diabetes.
    Sigal R; Malcolm J; Arnaout A
    Clin Evid; 2006 Jun; (15):623-45. PubMed ID: 16973029
    [No Abstract]   [Full Text] [Related]  

  • 8. [Prevention of ischemic cardiovascular complications in type 2 diabetes].
    Moulin P
    Journ Annu Diabetol Hotel Dieu; 2000; ():125-37. PubMed ID: 10932875
    [No Abstract]   [Full Text] [Related]  

  • 9. [Cardiovascular risk factors and their prevention].
    Philippe F
    Rev Prat; 2002 Dec; 52(20):2293-300. PubMed ID: 12621952
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cardiovascular diseases. From epidemiology to prevention].
    Jørgensen T; Willaing I; Thomsen TF
    Ugeskr Laeger; 2005 Mar; 167(10):1170-3. PubMed ID: 15810575
    [No Abstract]   [Full Text] [Related]  

  • 11. [Acetylsalicylic acid in patients with diabetes mellitus: can be used for secondary but not primary prevention of cardiovascular events].
    Klomp CM; ten Cate H; Stehouwer CD; Schaper NC
    Ned Tijdschr Geneeskd; 2009; 153():A109. PubMed ID: 19785798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prevention of cardiovascular risk in renal transplantation. Consensus document].
    Morales JM; González Molina M; Campistol JM; del Castillo D; Anaya F; Oppenheimer F; Gil Vernet JM; Grinyo JM; Capdevila L; Lampreave I; Valdés F; Marcén R; Escuín F; Andrés A; Arias M; Pallardó L
    Nefrologia; 2002; 22 Suppl 4():35-56. PubMed ID: 12123140
    [No Abstract]   [Full Text] [Related]  

  • 13. A polypill is the solution to the pharmacological management of cardiovascular risk: yes.
    Elley CR
    J Prim Health Care; 2009 Sep; 1(3):232-4. PubMed ID: 20690388
    [No Abstract]   [Full Text] [Related]  

  • 14. [Acetylsalicylic acid for the primary prevention of cardiovascular disease in diabetic patients].
    de Lange DW; Fiets WE; Banga JD
    Ned Tijdschr Geneeskd; 2004 Jul; 148(30):1481-5. PubMed ID: 15481570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacologic prevention of cardiovascular diseases--2005].
    Kancz S
    Orv Hetil; 2005 May; 146(20 Suppl 2):1122-31. PubMed ID: 15945241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular disease in diabetes.
    Sigal R; Malcolm J; Meggison H
    Clin Evid; 2002 Jun; (7):498-520. PubMed ID: 12230676
    [No Abstract]   [Full Text] [Related]  

  • 17. [Acetylsalicylic acid and diabetes mellitus].
    Paiva S
    Acta Med Port; 2002; 15(3):199-202. PubMed ID: 12379997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cardiovascular primary prevention must walk on both legs. Individual as well as public health measures are necessary].
    Nilsson PM
    Lakartidningen; 2005 Mar 7-13; 102(10):783, 785; discussion 785. PubMed ID: 15839173
    [No Abstract]   [Full Text] [Related]  

  • 19. Polypill in cardiovascular disease: has it's time come?
    Kuppuswamy V; Choo WK; Gupta S
    Indian Heart J; 2009; 61(4):322-7. PubMed ID: 20635733
    [No Abstract]   [Full Text] [Related]  

  • 20. [Arterial hypertension and the kidney].
    Niang A
    Dakar Med; 2008; 53(1):1-6. PubMed ID: 19102111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.